Moderna shares rally as investors bet on recent Hantavirus outbreak accelerating the biotech firm’s path to profitability. But there are ample reasons to avoid buying MRNA stock today.
Following AMD’s strong earnings and upgraded server CPU outlook, Intel is seeing renewed Wall Street optimism around its foundry progress and CPU pricing power.
Despite PepsiCo’s underperformance relative to the SPX over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Fluence Energy stock soars as Roth MKM doubles its price target to $26. Here’s why analyst Justin Clare turned super bullish on FLNC shares today.
Following robust Q4 2025 results of $770 million in revenue and reserve income, Circle’s upcoming May 11 earnings will test if its expanding USDC adoption, new enterprise payment platforms, and partnerships...
Innodata stock soars on a market-beating Q1 and impressive future guidance. Wall Street continues to see further upside in INOD shares in 2026.
AMD’s strong earnings momentum and growing AI partnerships have fueled a massive rally, but Cathie Wood seems to be locking in gains.
Strategy is evolving into a leveraged Bitcoin play layered with rising income features, leaving investors to weigh extreme volatility against Wall Street’s 'Strong Buy' consensus.
Despite Prologis’ outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
IonQ remains highly speculative, but surging backlog growth suggests enterprise customers are betting bigger on quantum computing.
